Drug Approval | April 22, 2026
US FDA okays Merck's new once-daily HIV pill
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
The approval of Cosentyx represents an important advancement for younger HS patients who have had limited treatment options
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
Occlutech develops, manufactures, and commercialises medical devices for congenital heart disease, stroke prevention, and heart failure
EYRA features intuitive software, automation readiness, and the ability to detect dozens of analytes simultaneously with minimal hands-on time
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
O'Connor brings over 30 years of leadership experience in the biotechnology and oncology sectors
The facility will offer fully equipped wet labs and strategic scientific support for early-stage biotech companies
Advancing toward Phase 2a evaluation in chemotherapy-related pain, a condition with no approved treatments and potential for FDA Fast Track designation
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
